3624 results for «454»

Filter By

3624 results

Left main and multivessel disease - Session 2

15 Dec 2022 – From GulfPCR-GIM 2022

View a sudden LM stem occlusion, a LM dissection during CTO, or even a rotablation in LM triple vessel disease in severe left ventricle dysfunction, and much more in this GulfPCR-GIM 2022 session.

Left main and multivessel disease - Session 2

Severe mitral and tricuspid regurgitation

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session aims to illustrate the role of mitral TEER in patients with significant MR and cardiogenic shock, to demonstrate the importance of early detection, but also to show that earlier referral and treatment of patients with significant TR is essential to prevent patients...

Severe mitral and tricuspid regurgitation

Bifurcation lesion - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session will get you thinking about how to best plan for severe left main bifurcation and severe calcification/low ejection fraction in non-surgical candidates, and how to manage difficult decisions in left main bifurcation stenting, among others!

Bifurcation lesion - Tools, devices and techniques

Gulf WIN - Opportunities and challenges

15 Dec 2022 – From GulfPCR-GIM 2022

Women have the floor in this special GulfPCR-GIM 2022 session: hear from members of the Gulf WIN (Women In Intervention) to better understand the status of women interventionists in the region, explore the challenges they face, and note the differences that exist with other women cardiologists...

Gulf WIN - Opportunities and challenges

CTO - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn how a left anterior descending in-stent CTO was rescued by epicardial retrograde wiring, how a guidewire was redirected using a dual lumen microcath, how a CTO intervention was treated in an anomalous right coronary artery, and more!

CTO - Tools, devices and techniques

Optimal management of a patient with calcified lesions - Session with LIVE case

15 Dec 2022 – From GulfPCR-GIM 2022

Watch the case of an 87-year-old male patient with DM, HTN, and hyperlipidemia, who suffered ACS six weeks ago, whose culprit lesions were treated in the RCA and LCX, and who was incidentally readmitted for LAD PCI, and find out how he was treated LIVE.

Optimal management of a patient with calcified lesions

Essential drugs that every interventionalist needs to know

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.

Essential drugs that every interventionalist needs to know

CABG vs. PCI - Multivessel disease

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to find out more about the guidelines in revascularisation for multivessel disease, simplification of multivessel disease PCI using physiological guidance, and much more!

CABG vs. PCI - Multivessel disease

All you need to know on physiology: a 2023 update

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, listen to William Wijns discuss the following physiology topics: long-term data on PCI deferral, update on new "negative" studies, low adoption in daily practice, and computational image-based physiology.    

All you need to know on physiology: a 2023 update

Optimising immediate and long-term outcomes after TAVI

29 Nov 2022 – From PCR London Valves 2022

This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.

Optimising immediate

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

27 Nov 2022 – From PCR London Valves 2022

In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

Reinventing the treatment of patients with tricuspid valve disease

28 Nov 2022 – From PCR London Valves 2022

This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.

Reinventing the treatment

The new PASCAL Precision system unleashes the full potential of mitral transcatheter edge-to-edge repair

28 Nov 2022 – From PCR London Valves 2022

Join this panel of experienced physicians to learn more about the novel PASCAL Precision system and to discuss implant selection and clinical data. Finally, participate in a recorded case demonstrating the use of the PASCAL Precision system for the treatment of mitral regurgitation.

The new PASCAL Precision

TAVI-in-TAVI - A road map for successful lifetime management

29 Nov 2022 – From PCR London Valves 2022

Join a team of experts that guide you through the basics of TAVI-in-TAVI, the procedural planning and techniques of implantation, followed by case examples with different index prostheses.

TAVI-in-TAVI - A road

Transcatheter mitral valve replacement - From planning to final assessment

27 Nov 2022 – From PCR London Valves 2022

In this session, a panel of experts share their experience with transcatheter mitral valve replacement and more specifically new planning and guidance tools using multiple imaging modalities.

Transcatheter mitral

HighLife TSMVR and their latest experiences, moving forward

29 Nov 2022 – From PCR London Valves 2022

A panel of experts review the latest clinical data, study progress and future plans regarding mitral valve replacement, and the position of HighLife, a new technology in this field.

HighLife TSMVR and their

Create the future of TAVI - Optimisation of the procedure and patient pathway

27 Nov 2022 – From PCR London Valves 2022

Dive into this session to discover what can be improved today to be ready to treat future TAVI patient volumes. You'll also learn how to set up a successful TAVI coordinating team and adopt it in your hospital, and how to create a win-win partnership with...

Create the future of

Remaining unmet needs and strategies in TAVI

28 Nov 2022 – From PCR London Valves 2022

Watch this session to understand why valve design impacts future patient outcomes and how hemodynamics can impact decision-making and the durability of the TAVI devices. At the end of the session, you'll also get an overview of Medtronic's portfolio.

Remaining unmet needs

Technical challenges and optimal device choice for complex TAVI procedures

28 Nov 2022 – From PCR London Valves 2022

This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Learn how to anticipate the risks of a valve-in-valve procedure in small surgical prostheses, and discover the latest technological evolutions for treating patients with complex anatomy.

Technical challenges

Innovations in TMVR and Intrepid trial updates

29 Nov 2022 – From PCR London Valves 2022

Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.

Innovations in TMVR and
Didn’t find what you were looking for?